Bristol-Myers Squibb (BMY) Stock Price

$59.6 0.1%

Sign up
to add to portfolio

AI Score

Sell

  • Alternative

    3

  • Fundamental

    3

  • Technical

    6

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Bristol-Myers Squibb, AI stock picks, stock alerts and much more.

Sign up

BMY AI Stock Analysis

AI stock analysis for BMY is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Bristol-Myers Squibb (BMY) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Bristol-Myers Squibb (BMY) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Bristol-Myers Squibb (BMY), currently trading at $59.6, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About BMY

LSE

  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide.

  • Symbol

    BMY

  • Market

    NYSE

  • Industry

    Drug Manufacturers - General

  • Market Cap

    121.3B

Similar Stocks

JNJ Johnson & Johnson
JNJ		 $155.4
1.4%
5
LLY Eli Lilly and Company
LLY		 $818.2
1.6%
6
PFE Pfizer
PFE		 $24.7
0.7%
3
ABBV AbbVie
ABBV		 $205.2
0.5%
5
MRK Merck & Company
MRK		 $86.6
0.6%
5

News

Is Bristol Myers Squibb's High-Yielding Dividend Safe?

Is Bristol Myers Squibb's High-Yielding Dividend Safe?
April 2, 2025. fool.com
CHMP Issues Positive Opinion for Label Expansion of BMY's Opdivo

CHMP Issues Positive Opinion for Label Expansion of BMY's Opdivo
April 1, 2025. zacks.com
Beat the S&P 500 With This Cash-Gushing Dividend Stock

Beat the S&P 500 With This Cash-Gushing Dividend Stock
April 1, 2025. fool.com
Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications
March 28, 2025. businesswire.com

BMY Alternative Data

Web Traffic

Bristol-Myers Squibb receives an estimated 692905 monthly visitors to bms.com.

  • Web Traffic

    692905

  • Change from Previous Month

    9.2%

  • 3 Month Change

    7.3%

  • YoY Change

    7.3%

News Mentions

Bristol-Myers Squibb was mentioned 6 times in the news yesterday.

  • News Mentions

    6

  • Daily Change

    50%

  • 1 Month Change

    500%

  • 3 Month Change

    50%

Reddit Mentions

Bristol-Myers Squibb has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

Twitter Followers

Bristol-Myers Squibb has 153,925 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.2% over the last month.

  • Twitter Followers

    153925

  • Daily Change

    0%

  • 1 Month Change

    0.2%

  • 3 Month Change

    0.7%

  • YoY Change

    0.7%

Facebook Engagement

Bristol-Myers Squibb has engaged 1,256 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    1256

  • Daily Change

    0.2%

  • 1 Month Change

    28.6%

  • 3 Month Change

    28%

  • YoY Change

    28%

Youtube Subscribers

Bristol-Myers Squibb has 3,820 subscribers on its main Youtube channel, up by 0.3% over the last month.

  • Youtube Subscribers

    3820

  • Daily Change

    0%

  • 1 Month Change

    0.3%

  • 3 Month Change

    1.9%

  • YoY Change

    1.9%

LinkedIn Followers

1,576,834 are following Bristol-Myers Squibb on LinkedIn, up by 1.2% over the last month.

  • LinkedIn Followers

    1576834

  • Daily Change

    0%

  • 1 Month Change

    1.2%

  • 3 Month Change

    3.7%

Job Postings

Bristol-Myers Squibb currenly has an estimated 664 open job postings, up by 22.1% over the last month.

  • Job Postings

    664

  • Daily Change

    2.2%

  • 1 Month Change

    22.1%

  • 3 Month Change

    4.7%

  • YoY Change

    4.7%

Instagram Followers

Bristol-Myers Squibb has 0 Instagram Followers on its main Instagram account.

  • Instagram Followers

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

LinkedIn Employees

According to LinkedIn, Bristol-Myers Squibb has 38,712 employees, up by 0% over the last month.

  • LinkedIn Employees

    38712

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    1.3%

  • YoY Change

    1.3%

Business Outlook

According to employee reviews, the business outlook among employees at Bristol-Myers Squibb is 48 out of 100 (neutral).

  • Business Outlook

    48

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

BMY Financials

BMY Key Metrics

  • Total Revenue

    $12.3B

  • Net Income

    $72M

  • Earnings per Share

    $0.0355

  • Free cash flow

    $4.1B

  • EBITDA

    $2.6B

  • EBITDA Ratio

    0.206693

  • Total Assets

    $92.6B

BMY 2-year Revenue & Income
BMY 2-year Free Cash Flow

BMY Technicals

BMY SMA
BMY RSI

FAQ

What's the current price of Bristol-Myers Squibb (BMY) Stock?
The price of an Bristol-Myers Squibb (BMY) share is $59.6.

What's the market cap of Bristol-Myers Squibb?
The current market cap of Bristol-Myers Squibb is 121.3B.

Should I buy or sell BMY?
Bristol-Myers Squibb exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.

Is Bristol-Myers Squibb a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Bristol-Myers Squibb stock. There are several bearish signals and market challenges that could negatively impact Bristol-Myers Squibb's future performance, suggesting that caution should be exercised before making any investment decisions.

Is now a good time to buy Bristol-Myers Squibb (BMY) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Bristol-Myers Squibb stock right now, as the outlook appears bearish.

What are some stocks similar to Bristol-Myers Squibb (BMY) that investors often compare it to?
Bristol-Myers Squibb (BMY) is often compared to similar stocks such as Johnson & Johnson, Eli Lilly and Company, Pfizer, AbbVie and Merck & Company.

What is the forecast for Bristol-Myers Squibb's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Bristol-Myers Squibb's stock price to be around $55.75 in 2026. Starting from the current price of $59.6, this represents a 6.5% change in price, indicating a bearish outlook for the stock.

How to buy Bristol-Myers Squibb (BMY) Stock?
Bristol-Myers Squibb stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Bristol-Myers Squibb shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.